Hepatitis B Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Regimens Containing Lenalidomide and/or Bortezomib
Taner DemirerMerih YalcinerErden AtillaRamazan İdilmanMeral BeksacPublished in: Turkish journal of haematology : official journal of Turkish Society of Haematology (2019)
Close follow-up is recommended for not only HBsAg-positive but also HBsAg-negative patients.